Skip to main content
Log in

Stellungnahme der Deutschen Gesellschaft für Rheumatologie zur Therapie der ankylosierenden Spondylitis (AS) mit Radiumchlorid (224SpondylAT®)

  • ORIGINALBEITRAG
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

, ., Kommission Pharmakotherapie. Stellungnahme der Deutschen Gesellschaft für Rheumatologie zur Therapie der ankylosierenden Spondylitis (AS) mit Radiumchlorid (224SpondylAT®). Z Rheumatol 60, 84–87 (2001). https://doi.org/10.1007/s003930170078

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s003930170078

Navigation